Nicholas Manes Caggiano, MD
Hand Surgery · San Luis Obispo
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 15 years
- Graduated 2011
Offices
2 locations · Central Coast Orthopedic Medical Group · David B. Hammer
Hospitals listed: Adventist Health Sierra Vista · Adventist Health Twin Cities · French Hospital Medical Center · Marian Regional Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Caggiano’s office at (805) 541-4600 to ask if they take your plan before you enroll.
California Medical Board record
Licence A148140 · Current
Licensed to practise in California · since 2017 · expires 2026-12-31 · Drexel University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Orthopaedic Surgery - Orthopaedic Surgery
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health Sierra VistaSan Luis Obispo, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 2 of 5 · 57% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.273, Oct 2024 – Sep 2025
- Adventist Health Twin CitiesTempleton, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 3 of 5 · 60% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.41, Oct 2024 – Sep 2025
- French Hospital Medical CenterSan Luis Obispo, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.23, Oct 2024 – Sep 2025
- Marian Regional Medical CenterSanta Maria, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 68% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.67 (0.37 to 0.96), Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.081, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Sierra Vista
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 1 better, 5 the same, 1 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.273 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.16 to 2.21) · 577 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.54 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 218.26 (161.19 to 275.34) · 33 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 31 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.6 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 19.1 · 175 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.5 · 76 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 874 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 2,390 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,282 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.97 (0.7 to 5.24) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.38) · 94 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.51 (0.92 to 4.09) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.57 (0 to 18.3) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.12 (0.83 to 9.41) · 80 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.99 (0.5 to 3.48) · 231 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.62 (0 to 1.53) · 2,070 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.7 · 35 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.729 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.63 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.924 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 73 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 67.8 · 79 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7 · 168 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 163 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.2 to 16.6) · 652 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (0.9 to 1.7) · 210 cases | No different | Jan 2024 – Dec 2024 |
What patients said (559 patients answered, 19% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 60% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 53% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 34% |
| "YES", patients would definitely recommend the hospital | 57% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Adventist Health Twin Cities
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.41 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 359 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.94 (0.51 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 66 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.7 · 198 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.6 · 335 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.9 · 113 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 1,156 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.48) · 2,873 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.5) · 2,701 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.28 (1.85 to 6.72) · 375 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.53 (0.84 to 4.22) · 371 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.14 (0 to 19.18) · 39 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.21 (0.88 to 9.54) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.22) · 97 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 2,369 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 41 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.704 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 40.3 · 216 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 6.5 · 313 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.5 · 39 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.9 · 69 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (10.4 to 18.7) · 246 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.4) · 220 cases | No different | Jan 2024 – Dec 2024 |
What patients said (555 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 35% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for French Hospital Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.23 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.89 (0 to 1.89) · 660 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.71 (0.39 to 1.04) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 154.33 (99.56 to 209.1) · 63 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.9 · 56 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 273 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.7 · 355 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 275 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.5 · 69 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 1,569 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 4,085 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.07 to 0.47) · 4,358 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.69 (0.53 to 4.85) · 1,221 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.97 (0.47 to 3.48) · 567 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.54 (1.03 to 4.05) · 1,101 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.3 (0.36 to 12.23) · 585 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.66 (0.03 to 7.29) · 576 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.98 (0.5 to 3.47) · 185 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.2 (0 to 0.96) · 3,231 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 53 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 2.935 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.6 · 252 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 330 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -2.9 · 296 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -8.5 · 382 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2 · 272 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.7 (6.5 to 14.1) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 40 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10 · 77 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.7 (8.9 to 15.1) · 837 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 706 cases | No different | Jan 2024 – Dec 2024 |
What patients said (706 patients answered, 28% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 5 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 33% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Marian Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.67 (0.37 to 0.96) | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.081 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0.06 to 1.93) · 1,191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 189.73 (139.29 to 240.17) · 66 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.7 · 103 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 15.9 · 247 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 478 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 470 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 237 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 3,050 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.34) · 8,823 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.42) · 8,672 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.87 (0.97 to 4.76) · 2,024 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.12 (0.57 to 3.67) · 782 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.29 (0.85 to 3.72) · 1,934 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 3.63 (0 to 9.97) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.01 (1.37 to 8.65) · 748 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.88 (0.43 to 3.32) · 373 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.13 (0 to 0.73) · 6,968 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 179 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.245 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.85 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.952 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.687 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 198 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.6 · 469 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.8 · 232 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.8 · 541 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8.6 · 473 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 434 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.6 (5 to 8.4) · 519 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.9 (8.8 to 13.4) · 519 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.3 · 83 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.2 to 17) · 124 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 638 cases | No different | Jan 2024 – Dec 2024 |
What patients said (666 patients answered, 17% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$552,921
Medicare paid this office $552,921 for 1,109 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, collagenase, clostridium histolyticum, 0.01 mg | 29 | $241,645 | None |
| New patient visit (45+ min) | 324 | $38,197 | $118 |
| Return visit (30+ min) | 325 | $35,881 | $90 |
| Release and/or relocation of hand nerve | 73 | $26,635 | $341 |
| Short return visit (20+ min) | 298 | $23,105 | $66 |
See all 32 services
| Injection, collagenase, clostridium histolyticum, 0.01 mg | 29 | $241,645 | None |
| New patient visit (45+ min) | 324 | $38,197 | $118 |
| Return visit (30+ min) | 325 | $35,881 | $90 |
| Release and/or relocation of hand nerve | 73 | $26,635 | $341 |
| Short return visit (20+ min) | 298 | $23,105 | $66 |
| Removal of connective tissue of palm and release of finger, first digit | 26 | $17,589 | $676 |
| New patient visit (30+ min) | 228 | $17,221 | $76 |
| Injection into tendon or ligament | 249 | $13,484 | $38 |
| Removal of bone joints between wrist and fingers | 15 | $11,216 | $660 |
| X-ray of finger, minimum of 2 views | 213 | $8,073 | $30 |
| Aspiration and/or injection of fluid from small joint | 150 | $8,003 | $41 |
| Incision of tendon covering of finger | 25 | $6,306 | $191 |
| Release of hand muscle | 19 | $5,478 | $274 |
| Placement of single direction external bone stabilizing device to arm or leg | 11 | $5,162 | $469 |
| X-ray of wrist, 2 views | 131 | $4,955 | $28 |
| Removal of growth of tendon finger or hand | 17 | $4,383 | $231 |
| Removal of wrist bone | 15 | $4,119 | $229 |
| X-ray of hand, 2 views | 119 | $4,010 | $26 |
| Manipulation of finger for connective tissue release following enzyme injection | 29 | $3,934 | $80 |
| Partial release of connective tissue of palm | 11 | $2,170 | $197 |
| Injection of medication into palm | 29 | $2,092 | $42 |
| Application of elbow to finger cast | 24 | $1,867 | $69 |
| Aspiration and/or injection of fluid from medium joint | 33 | $1,500 | $39 |
| X-ray of hand, minimum of 3 views | 24 | $1,230 | $32 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 404 | $1,158 | None |
| Injection of carpal tunnel | 17 | $1,102 | $65 |
| Application of nonmoveable forearm to hand splint | 29 | $923 | $31 |
| X-ray of wrist, minimum of 3 views | 20 | $862 | $36 |
| Cast supplies, short arm cast, adult (11 years +), fiberglass | 25 | $670 | $19 |
| Aspiration and/or injection of cyst of tendon | 12 | $542 | $45 |
| Cast supplies, short arm splint, adult (11 years +), fiberglass | 27 | $326 | $12 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 11 | $131 | $12 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of nail tissue | 1-10 | None |
| Removal of tissue | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection into tendon or ligament | 278 | 310 | 296 | 315 | 293 | 353 |
| Aspiration and/or injection of fluid from small joint | 151 | 182 | 174 | 225 | 184 | 194 |
| Release and/or relocation of hand nerve | 67 | 64 | 57 | 77 | 86 | 78 |
| Injection of medication into palm | 50 | 45 | 55 | 60 | 70 | 50 |
| Manipulation of finger for connective tissue release following enzyme injection | 46 | 38 | 49 | 53 | 63 | 49 |
| Application of nonmoveable forearm to hand splint | 129 | – | 12 | 41 | 34 | 30 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,109 Original Medicare patients in 2024. Average age 74 · Under 65 3% · 85 and older 7% · Women 59% · Also on Medicaid 10% · Health risk score 0.86. At or below the middle of the specialty; the typical hand surgery clinician is at 1.08.
Conditions among them: High blood pressure 64% · Coronary heart disease 18% · Diabetes 17% · Depression 17% · Chronic kidney disease 15% · Cancer 14% · Atrial fibrillation 12% · COPD 9% · Heart failure 7% · Stroke 4% · Dementia 2%.
The office billed $1,283,415, Medicare allowed $723,689 and paid $552,921; for 9,303 services of 103 kinds; $242,803 of it was for drugs given in the office and $310,118 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,109 | 9,303 | 74 | 0.86 | $1,283,415 | $552,921 |
| 2023 | 1,034 | 10,543 | 73 | 0.79 | $1,289,948 | $604,555 |
| 2022 | 825 | 10,311 | 73 | 0.76 | $1,144,829 | $514,243 |
| 2021 | 817 | 8,622 | 73 | 0.81 | $925,751 | $445,551 |
| 2020 | 821 | 7,389 | 73 | 0.87 | $896,729 | $372,298 |
| 2019 | 864 | 8,376 | 73 | 0.92 | $994,653 | $408,963 |
| 2018 | 740 | 5,405 | 72 | 0.90 | $632,667 | $248,545 |
| 2017 | 243 | 1,594 | 72 | 0.91 | $190,811 | $77,572 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 27 services
| Injection, collagenase, clostridium histolyticum, 0.01 mg | 40 | $311,648 | None |
| New patient visit (45+ min) | 376 | $46,101 | $123 |
| Return visit (30+ min) | 292 | $34,469 | $93 |
| Release and/or relocation of hand nerve | 78 | $28,797 | $335 |
| Short return visit (20+ min) | 349 | $28,326 | $65 |
| New patient visit (30+ min) | 240 | $19,103 | $80 |
| Injection into tendon or ligament | 208 | $11,238 | $38 |
| Removal of bone joints between wrist and fingers | 15 | $10,270 | $685 |
| Treatment of 3 or more broken lower forearm bone pieces on thumb side inside wrist joint with placement of stabilizing device | 12 | $9,907 | $826 |
| Removal of connective tissue of palm and release of finger, first digit | 13 | $9,474 | $677 |
| Aspiration and/or injection of fluid from small joint | 133 | $7,658 | $42 |
| Incision of tendon covering of finger | 23 | $6,204 | $214 |
| X-ray of finger, minimum of 2 views | 144 | $5,851 | $30 |
| Manipulation of finger for connective tissue release following enzyme injection | 39 | $4,879 | $77 |
| X-ray of wrist, 2 views | 119 | $4,589 | $28 |
| Injection of medication into palm | 42 | $3,646 | $52 |
| Removal of wrist bone | 15 | $3,084 | $206 |
| X-ray of hand, 2 views | 84 | $3,061 | $26 |
| Application of elbow to finger cast | 34 | $2,851 | $70 |
| Aspiration and/or injection of fluid from medium joint | 30 | $1,352 | $40 |
| X-ray of wrist, minimum of 3 views | 29 | $1,189 | $34 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 347 | $1,154 | None |
| Injection of carpal tunnel | 14 | $1,146 | $67 |
| Application of nonmoveable forearm to hand splint | 34 | $1,001 | $29 |
| Cast supplies, short arm cast, adult (11 years +), fiberglass | 32 | $707 | $18 |
| X-ray of hand, minimum of 3 views | 12 | $456 | $30 |
| Cast supplies, short arm splint, adult (11 years +), fiberglass | 35 | $386 | $11 |
2022: 26 services
| Injection, collagenase, clostridium histolyticum, 0.01 mg | 43 | $264,860 | None |
| Short return visit (20+ min) | 357 | $30,958 | $65 |
| Return visit (30+ min) | 251 | $29,572 | $93 |
| New patient visit (45+ min) | 218 | $25,811 | $118 |
| Release and/or relocation of hand nerve | 69 | $25,665 | $333 |
| New patient visit (30+ min) | 205 | $16,186 | $79 |
| Injection into tendon or ligament | 203 | $12,008 | $38 |
| Removal of bone joints between wrist and fingers | 13 | $9,558 | $683 |
| Incision of tendon covering of finger | 32 | $8,032 | $187 |
| Aspiration and/or injection of fluid from small joint | 135 | $7,842 | $35 |
| X-ray of finger, minimum of 2 views | 116 | $4,853 | $30 |
| Manipulation of finger for connective tissue release following enzyme injection | 41 | $4,546 | $86 |
| X-ray of wrist, 2 views | 96 | $3,685 | $29 |
| Injection of medication into palm | 44 | $3,067 | $51 |
| Application of elbow to finger cast | 38 | $2,843 | $69 |
| X-ray of hand, 2 views | 71 | $2,274 | $24 |
| Injection of carpal tunnel | 19 | $1,524 | $63 |
| Aspiration and/or injection of fluid from medium joint | 32 | $1,432 | $37 |
| Application of nonmoveable forearm to hand splint | 41 | $1,229 | $30 |
| X-ray of wrist, minimum of 3 views | 25 | $1,125 | $36 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 227 | $885 | None |
| Cast supplies, short arm cast, adult (11 years +), fiberglass | 38 | $708 | $17 |
| Injection, methylprednisolone acetate, 20 mg | 169 | $612 | None |
| X-ray of hand, minimum of 3 views | 13 | $476 | $32 |
| Cast supplies, short arm splint, adult (11 years +), fiberglass | 39 | $411 | $11 |
| Injection, methylprednisolone acetate, 40 mg | 15 | $42 | None |
2021: 28 services
| Injection, collagenase, clostridium histolyticum, 0.01 mg | 40 | $236,087 | None |
| Short return visit (20+ min) | 348 | $31,861 | $73 |
| Return visit (30+ min) | 221 | $24,581 | $97 |
| New patient visit (45+ min) | 196 | $23,934 | $122 |
| Release and/or relocation of hand nerve | 49 | $20,205 | $354 |
| New patient visit (30+ min) | 240 | $19,041 | $79 |
| Injection into tendon or ligament | 190 | $11,500 | $39 |
| Aspiration and/or injection of fluid from small joint | 130 | $7,019 | $40 |
| X-ray of finger, minimum of 2 views | 126 | $4,889 | $31 |
| Incision of tendon covering of finger | 21 | $4,877 | $181 |
| Manipulation of finger for connective tissue release following enzyme injection | 39 | $4,225 | $86 |
| X-ray of wrist, 2 views | 87 | $4,213 | $29 |
| Injection of medication into palm | 41 | $3,619 | $66 |
| X-ray of hand, 2 views | 61 | $2,357 | $26 |
| Application of elbow to finger cast | 29 | $2,119 | $71 |
| Injection of carpal tunnel | 24 | $2,070 | $69 |
| Short return visit | 27 | $1,420 | $46 |
| Aspiration and/or injection of fluid from medium joint | 27 | $1,171 | $42 |
| Injection, methylprednisolone acetate, 20 mg | 262 | $1,091 | None |
| X-ray of wrist, minimum of 3 views | 24 | $935 | $33 |
| Application of nonmoveable finger splint | 34 | $686 | $20 |
| Aspiration and/or injection of cyst of tendon | 14 | $587 | $42 |
| X-ray of hand, minimum of 3 views | 16 | $573 | $30 |
| Cast supplies, short arm cast, adult (11 years +), fiberglass | 29 | $506 | $16 |
| Application of nonmoveable forearm to hand splint | 12 | $362 | $30 |
| Injection, methylprednisolone acetate, 80 mg | 35 | $359 | None |
| Injection, methylprednisolone acetate, 40 mg | 53 | $268 | None |
| Finger splint, static | 11 | $18 | $2 |
2020: 28 services
| Injection, collagenase, clostridium histolyticum, 0.01 mg | 26 | $157,331 | None |
| New patient visit (30+ min) | 496 | $38,263 | $77 |
| Short return visit (20+ min) | 314 | $23,387 | $57 |
| Release and/or relocation of hand nerve | 61 | $21,303 | $333 |
| Return visit (30+ min) | 207 | $20,305 | $80 |
| Injection into tendon or ligament | 186 | $11,536 | $37 |
| Treatment of 3 or more broken lower forearm bone pieces on thumb side inside wrist joint with placement of stabilizing device | 12 | $10,610 | $884 |
| Aspiration and/or injection of fluid from small joint | 139 | $6,921 | $38 |
| X-ray of finger, minimum of 2 views | 132 | $5,095 | $28 |
| Incision of tendon covering of finger | 23 | $5,093 | $212 |
| Injection of carpal tunnel | 52 | $3,897 | $60 |
| Application of elbow to finger cast | 47 | $3,650 | $70 |
| X-ray of wrist, minimum of 3 views | 58 | $3,345 | $33 |
| X-ray of wrist, 2 views | 84 | $3,156 | $26 |
| Manipulation of finger for connective tissue release following enzyme injection | 26 | $3,111 | $82 |
| Injection of medication into palm | 27 | $2,511 | $56 |
| Aspiration and/or injection of fluid from medium joint | 40 | $1,885 | $39 |
| X-ray of hand, 2 views | 43 | $1,442 | $25 |
| Injection, methylprednisolone acetate, 20 mg | 280 | $1,344 | None |
| Short return visit | 31 | $1,101 | $36 |
| Cast supplies, short arm cast, adult (11 years +), fiberglass | 48 | $883 | $16 |
| Aspiration and/or injection of cyst of tendon | 17 | $844 | $50 |
| Application of nonmoveable finger splint | 31 | $730 | $22 |
| X-ray of hand, minimum of 3 views | 18 | $665 | $29 |
| Injection, methylprednisolone acetate, 80 mg | 44 | $468 | None |
| Injection, methylprednisolone acetate, 40 mg | 76 | $453 | None |
| Placement of strapping to hand or finger | 11 | $249 | $23 |
| Finger splint, static | 11 | $21 | $2 |
2019: 28 services
| Injection, collagenase, clostridium histolyticum, 0.01 mg | 37 | $171,795 | None |
| New patient visit (30+ min) | 589 | $45,509 | $77 |
| Return visit (30+ min) | 267 | $32,410 | $85 |
| Short return visit (20+ min) | 308 | $26,521 | $56 |
| Release and/or relocation of hand nerve | 58 | $22,087 | $330 |
| Injection into tendon or ligament | 195 | $10,472 | $38 |
| Removal of bone joints between wrist and fingers | 15 | $9,599 | $640 |
| X-ray of wrist, minimum of 3 views | 149 | $8,389 | $31 |
| Application of nonmoveable forearm to hand splint | 120 | $6,724 | $52 |
| Application of moveable or hinged forearm to hand splint | 77 | $5,382 | $69 |
| Aspiration and/or injection of fluid from small joint | 114 | $5,020 | $33 |
| Incision of tendon covering of finger | 14 | $3,881 | $243 |
| Application of elbow to finger cast | 42 | $3,790 | $70 |
| Manipulation of finger for connective tissue release following enzyme injection | 36 | $3,429 | $75 |
| X-ray of finger, minimum of 2 views | 90 | $3,322 | $27 |
| Injection of medication into palm | 37 | $3,093 | $62 |
| Incision or the tendon covering on the top side of the wrist | 15 | $2,388 | $159 |
| Aspiration and/or injection of cyst of tendon | 39 | $1,734 | $43 |
| Aspiration and/or injection of fluid from medium joint | 28 | $1,331 | $39 |
| X-ray of hand, minimum of 3 views | 31 | $1,324 | $27 |
| X-ray of wrist, 2 views | 40 | $1,233 | $27 |
| Injection, methylprednisolone acetate, 20 mg | 238 | $1,121 | None |
| Cast supplies, short arm cast, adult (11 years +), fiberglass | 43 | $958 | $16 |
| X-ray of hand, 2 views | 29 | $834 | $24 |
| Injection, methylprednisolone acetate, 80 mg | 59 | $704 | None |
| Application of nonmoveable finger splint | 36 | $678 | $17 |
| Placement of strapping to hand or finger | 13 | $242 | $19 |
| Injection, methylprednisolone acetate, 40 mg | 34 | $213 | None |
2018: 26 services
| Injection, collagenase, clostridium histolyticum, 0.01 mg | 19 | $89,489 | None |
| New patient visit (30+ min) | 446 | $34,364 | $77 |
| Short return visit (20+ min) | 371 | $33,236 | $54 |
| Return visit (30+ min) | 138 | $13,129 | $83 |
| Release and/or relocation of hand nerve | 34 | $11,429 | $327 |
| X-ray of wrist, minimum of 3 views | 144 | $7,701 | $29 |
| Injection into tendon or ligament | 156 | $7,022 | $38 |
| Application of elbow to finger cast | 46 | $4,805 | $69 |
| Application of moveable or hinged forearm to hand splint | 66 | $4,250 | $64 |
| Application of nonmoveable forearm to hand splint | 75 | $4,019 | $54 |
| Incision of tendon covering of finger | 14 | $3,605 | $240 |
| Aspiration and/or injection of fluid from small joint | 81 | $2,922 | $28 |
| Manipulation of finger for connective tissue release following enzyme injection | 19 | $1,940 | $69 |
| Injection of medication into palm | 19 | $1,659 | $57 |
| X-ray of finger, minimum of 2 views | 48 | $1,615 | $25 |
| Aspiration and/or injection of fluid from medium joint | 34 | $1,289 | $36 |
| Cast supplies, short arm cast, adult (11 years +), fiberglass | 46 | $1,229 | $15 |
| X-ray of hand, minimum of 3 views | 32 | $844 | $22 |
| Injection, methylprednisolone acetate, 20 mg | 176 | $810 | None |
| X-ray of wrist, 2 views | 18 | $691 | $27 |
| Aspiration and/or injection of cyst of tendon | 11 | $574 | $48 |
| Application of nonmoveable finger splint | 24 | $533 | $22 |
| X-ray of hand, 2 views | 18 | $381 | $17 |
| Injection, methylprednisolone acetate, 40 mg | 58 | $314 | None |
| Injection, methylprednisolone acetate, 80 mg | 20 | $210 | None |
| Finger splint, static | 11 | $18 | $2 |
2017: 11 services
| Short return visit (20+ min) | 156 | $14,178 | $60 |
| New patient visit (30+ min) | 117 | $10,286 | $88 |
| Injection into tendon or ligament | 41 | $2,095 | $43 |
| X-ray of wrist, minimum of 3 views | 37 | $1,909 | $30 |
| Application of elbow to finger cast | 14 | $1,665 | $72 |
| Aspiration and/or injection of fluid from small joint | 25 | $1,161 | $37 |
| X-ray of hand, minimum of 3 views | 23 | $803 | $26 |
| X-ray of finger, minimum of 2 views | 19 | $770 | $27 |
| Cast supplies, short arm cast, adult (11 years +), fiberglass | 14 | $349 | $15 |
| Injection, methylprednisolone acetate, 40 mg | 37 | $207 | None |
| Injection, methylprednisolone acetate, 20 mg | 35 | $164 | None |
Medicaid work
$22,455 in 2024
Medicaid paid $22,455 for 190 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 45 | $8,631 |
| Return visit (30+ min) | 40 | $4,949 |
| New patient visit (30+ min) | 31 | $4,596 |
| Short return visit (20+ min) | 45 | $4,192 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 29 | $86 |
| 2024 | 190 | 5 | 18 | $22,455 |
| 2023 | 301 | 6 | 20 | $34,168 |
| 2022 | 57 | 1 | 16 | $7,477 |
| 2021 | 87 | 2 | 19 | $12,650 |
| 2020 | 130 | 2 | 20 | $17,942 |
| 2019 | 175 | 2 | 19 | $23,455 |
| 2018 | 183 | 2 | 22 | $21,169 |
See the largest Medicaid services in earlier years
2023
| New patient visit (45+ min) | 98 | $17,452 |
| Short return visit (20+ min) | 65 | $6,173 |
| New patient visit (30+ min) | 45 | $6,073 |
| Return visit (30+ min) | 29 | $3,571 |
| Injection(s); single tendon sheath, or ligament, aponeurosis (eg, plantar "fascia") | 14 | $763 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 50 | $137 |
2022
| Short return visit (20+ min) | 57 | $7,477 |
2021
| Short return visit (20+ min) | 74 | $9,742 |
| New patient visit (45+ min) | 13 | $2,908 |
2020
| New patient visit (30+ min) | 100 | $15,323 |
| Short return visit (20+ min) | 30 | $2,619 |
2019
| New patient visit (30+ min) | 114 | $17,197 |
| Short return visit (20+ min) | 61 | $6,258 |
2018
| Short return visit (20+ min) | 116 | $11,262 |
| New patient visit (30+ min) | 67 | $9,907 |
Drugs they prescribed that Part D paid
$71,984
Pharmacies billed $71,984 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 69% of their Part D prescriptions (99 of 144) in 2024. Above the middle of the specialty; the typical hand surgery clinician is at 47%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
137 generic and fewer than 11 brand-name prescriptions · $71,984 in drug cost · 26 antibiotic prescriptions to 20 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 67 | $340 | $5 |
| Cephalexin | 14 | $204 | $14 |
| Tramadol | 21 | $43 | $2 |
Year by year
| 2024 | 144 | 116 | 69% (99) | None | $71,984 |
| 2023 | 134 | 93 | 48% (64) | None | $70,450 |
| 2022 | 123 | 93 | 52% (64) | 9% | $89,556 |
| 2021 | 126 | 85 | 33% (41) | None | $1,392 |
| 2020 | 183 | 109 | 29% (53) | None | $2,356 |
| 2019 | 131 | 110 | 53% (70) | 14% | $54,930 |
| 2018 | 77 | 51 | 58% (45) | None | $18,457 |
| 2017 | 33 | 27 | 73% (24) | None | $8,618 |
| 2016 | 45 | 29 | 60% (27) | None | $854 |
| 2015 | 60 | 38 | 63% (38) | None | $1,824 |
| 2014 | 73 | 44 | 48% (35) | 21% | $5,954 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Cephalexin | 31 | $357 | $12 |
| Hydrocodone-Acetaminophen | 50 | $280 | $6 |
| Doxycycline Hyclate | 13 | $140 | $11 |
2022: 3 drugs
| Xiaflex | 11 | $88,684 | $8,062 |
| Hydrocodone-Acetaminophen | 51 | $281 | $6 |
| Cephalexin | 24 | $215 | $9 |
2021: 3 drugs
| Diclofenac | 16 | $488 | $31 |
| Cephalexin | 35 | $398 | $11 |
| Hydrocodone-Acetaminophen | 32 | $105 | $3 |
2020: 4 drugs
| Diclofenac | 28 | $1,400 | $50 |
| Cephalexin | 45 | $250 | $6 |
| Hydrocodone-Acetaminophen | 49 | $212 | $4 |
| Clindamycin | 18 | $154 | $9 |
2019: 2 drugs
| Diclofenac | 29 | $2,515 | $87 |
| Hydrocodone-Acetaminophen | 63 | $235 | $4 |
2018: 2 drugs
| Hydrocodone-Acetaminophen | 19 | $146 | $8 |
| Tramadol | 24 | $48 | $2 |
2017: 1 drug
| Oxycodone | 14 | $148 | $11 |
2016: 1 drug
| Tramadol | 12 | $51 | $4 |
2015: 2 drugs
| Oxycodone | 14 | $230 | $16 |
| Tramadol | 20 | $70 | $4 |
2014: 2 drugs
| Oxycodone | 15 | $256 | $17 |
| Tramadol | 11 | $43 | $4 |
Money from drug and device companies
$59 in 2025
| 2025 | 3 | 3 | None | $59 |
| 2023 | 2 | 2 | None | $39 |
| 2022 | 2 | 2 | None | $33 |
| 2020 | 2 | 2 | None | $128 |
| 2019 | 2 | 14 | None | $1,150 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| DePuy Synthes Sales | VA-Lcp | $26 | 1 payment
|
| Cornerstone Medical Associates | None | $17 | 1 payment
|
| Djo | Aircast | $16 | 1 payment
|
See all 3 published payments
| DePuy Synthes Sales | Meals · 2025-10-05 | VA-Lcp | $26 |
| Djo | Meals · 2025-07-15 | Aircast | $16 |
| Cornerstone Medical Associates | Meals · 2025-03-13 | None | $17 |
See earlier years (2023, 2022, 2020, 2019)
2023: $39
| Orthofix Medical | Physio-Stim | $21 | 1 payment
|
| Bioventus | Exogen Ultrasound Bone Healing System | $18 | 1 payment
|
2022: $33
| Medtronic | Synchromedii | $19 | 1 payment
|
| Endo Pharmaceuticals | Xiaflex | $14 | 1 payment
|
2020: $128
| Skeletal Dynamics | Geminus | $110 | 1 payment
|
| Endo Pharmaceuticals | Xiaflex | $19 | 1 payment
|
2019: $1,150
| Axogen | Axoguard Nerve Connector | $1,134 | 3 payments
|
| Endo Pharmaceuticals | Xiaflex | $17 | 1 payment
|
Checkups this office reported
6 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 82.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Advance care plan on fileOlder patients with an advance care plan or a documented conversation about one | 99%That's most of the people this applied to. | 1,232 |
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 48%That's less than half. | 52 |
| Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and OlderAs Medicare defines this measure | 90% | 244 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 96%That's most of the people this applied to. | 895 |
| Screening for Osteoporosis for Women Aged 65-85 Years of AgeAs Medicare defines this measure | 49% | 659 |
| Tobacco Use and Help with Quitting Among AdolescentsAs Medicare defines this measure | 95% | 116 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Checks the state prescription-drug database before prescribing
- Did a security review of patient data
- Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
- Reports cases to public health electronically
- Reports to a public-health or clinical registry
- Tracking of clinicians relationship to and responsibility for a patient by reporting MACRA patient relationship codes.
- Exempt from immunization registry reporting
- Exempt from support electronic referral loops by sending health information
Professional record
- NPI
- 1306133699
- Licence
- CA A148140California A148140: Current · expires 2026-12-31
- Group
- Central Coast Orthopedic Medical Group · David B. Hammer
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2086S0105X (2086S0105X)
- Mailing address
- 862 Meinecke Ave Ste 100, San Luis Obispo, CA, 93405
- NPI first listed
- 2011-07-07
- NPI last updated
- 2023-08-16
- NPI record certified
- 2023-08-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 921 Oak Park Blvd Ste 204, Pismo Beach, CA, 93449